|Bid||0.0000 x N/A|
|Ask||0.0000 x N/A|
|Day's range||0.0000 - 0.0000|
|Beta (5Y monthly)||0.93|
|PE ratio (TTM)||N/A|
|Earnings date||15 Mar 2023 - 20 Mar 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Ginkgo is teaming up with Synlogic to launch a new gout drug, moving shares of both stocks higher.
Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of 4.35% and 49.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?